Detalles de la búsqueda
1.
Long-term Outcome of Risankizumab in Crohn's Disease: a Real-world GETAID Study.
Clin Gastroenterol Hepatol
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38729389
2.
Role of adherent and invasive Escherichia coli in Crohn's disease: lessons from the postoperative recurrence model.
Gut
; 72(1): 39-48, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35361684
3.
Switching From Intravenous to Subcutaneous Infliximab is Safe and Feasible in Patients With Inflammatory Bowel Disease Suffering From Obesity: A Post Hoc Analysis of the REMSWITCH Study.
Clin Gastroenterol Hepatol
; 2023 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37802269
4.
Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 21(5): 1354-1355.e2, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35307594
5.
Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study.
Clin Gastroenterol Hepatol
; 21(9): 2338-2346.e3, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35987302
6.
Adalimumab in Biologic-naïve Patients With Crohn's Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAID.
Clin Gastroenterol Hepatol
; 21(13): 3365-3378.e5, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36731588
7.
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial.
Clin Gastroenterol Hepatol
; 20(9): 2074-2082, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34843987
8.
Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study.
Clin Gastroenterol Hepatol
; 20(4): 787-797.e2, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33359726
9.
Efficacy and Safety of Infliximab Retreatment in Crohn's Disease: A Multicentre, Prospective, Observational Cohort (REGAIN) Study from the GETAID.
Am J Gastroenterol
; 117(9): 1482-1490, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35973142
10.
Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis: a GETAID multicentre cohort study.
Scand J Gastroenterol
; 57(12): 1454-1462, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35819361
11.
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study.
BMC Gastroenterol
; 22(1): 498, 2022 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36457080
12.
Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study.
Dig Dis Sci
; 67(9): 4525-4532, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35246801
13.
A European Survey on Digestive Perianastomotic Ulcerations, a Rare Crohn-like Disorder Occurring in Children and Young Adults.
J Pediatr Gastroenterol Nutr
; 73(3): 333-337, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34117192
14.
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium.
PLoS Med
; 17(10): e1003348, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33125391
15.
Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial.
Clin Gastroenterol Hepatol
; 18(7): 1553-1560.e1, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31470175
16.
Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn's Disease.
Clin Gastroenterol Hepatol
; 18(3): 628-636, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31128337
17.
Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease.
Dig Dis Sci
; 65(5): 1445-1452, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31599389
18.
Radiological Response Is Associated with Better Outcomes and Should Be Considered a Therapeutic Target in Crohn's Disease.
Dig Dis Sci
; 65(9): 2664-2674, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31811438
19.
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease.
Gastroenterology
; 154(5): 1334-1342.e4, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29277560
20.
Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 17(3): 494-501, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30213584